The Daily Folgen

The C.I.A. sent a short but explosive message last week to all of its stations and bases around the world.The cable, which said dozens of sources had been arrested, killed or turned against the United States, highlights the struggle the agency is having as it works to recruit spies around the world. How did this deterioration occur?Guest: Julian E. Barnes, a national security reporter for The New York Times. Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Counterintelligence officials said in a top secret cable to all stations and bases around the world that too many of the people it recruits from other countries to spy for the U.S. are being lost.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

The coronavirus seems to be in retreat in the United States, with the number of cases across the country down about 25 percent compared with a couple of weeks ago. Hospitalizations and deaths are also falling.So, what stage are we in with the pandemic? And how will developments such as a new antiviral treatment and the availability of booster shots affect things?Guest: Apoorva Mandavilli, a science and global health reporter for The New York Times. Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: The authorization for booster shots applies to groups of people in the United States fully vaccinated with the Pfizer vaccine, but about 45 percent of the country’s fully inoculated people received Moderna or Johnson & Johnson doses.Merck said it would seek authorization for molnupiravir, an antiviral pill that the company says is effective against Covid. Experts said such treatments could be a powerful tool against the virus.Despite a fall in new cases, hospitalizations and deaths, public health officials said the pandemic remained a potent threat.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

The Senate testimony of Frances Haugen on Tuesday was an eagerly awaited event.Last month, Ms. Haugen, a former Facebook product manager, leaked internal company documents to The Wall Street Journal that exposed the social media giant’s inner workings.How will Ms. Haugen’s insights shape the future of internet regulation?Guest: Sheera Frenkel, a technology reporter for The New York Times. Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: Ms. Haugen told how Facebook deliberately made efforts to keep users — including children — hooked to its service.Here are other key takeaways from her testimony.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.